Viral Vaccines in India: An Overview

  title={Viral Vaccines in India: An Overview},
  author={Kaushik Bharati and S. Vrati},
  journal={Proceedings of the National Academy of Sciences, India. Section B},
  pages={181 - 198}
Viruses cause a large number of diseases in humans, some of which are fatal, while others are highly debilitating. A majority of viral diseases attack infants and young children, while others strike people in their prime. Development of preventive measures against viral diseases is, therefore, of paramount importance. Vaccination is the most cost-effective medical intervention for preventing mortality and morbidity against infectious diseases. A number of effective and safe vaccines are… Expand
Fight against dengue in India: progresses and challenges
An urgent need for permanent surveillance programs, coupled with improvised disease diagnostics, effective anti-dengue treatment measures, and controlling the disease transmission by following an effective implementation of vector control programs is revealed. Expand
A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2
The unprecedented coronavirus disease 2019 (COVID-19) is triggered by a novel strain of coronavirus namely, Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). Researchers are workingExpand


Important Advances in the Field of Anti-Dengue Virus Research
This review focuses on recent developments in the AG129 mouse model and discusses compounds that have been found to be active in available cell and animal model systems within the past year. Expand
IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine
IMOJEV was found to be safe, highly immunogenic and capable of inducing long-lasting immunity in both preclinical and clinical trials, and may be licensed for use in humans as an improved alternative to the currently licensed JE vaccines. Expand
Recombinant glycoprotein based vaccine for Chandipura virus infection.
The study shows that rGp induces both arms of immune response and represents an ideal vaccine candidate for further evaluations. Expand
Influenza activity among the paediatric age group in Chennai.
Isolation of influenza A and B viruses indicated a significant activity of these viruses in Chennai, and the predominance of A/H3N2/ Panama is an indication that the Indian scenario is similar to the global picture of influenza activity. Expand
Influenza vaccination for children in India.
Current aggressive marketing of the vaccine and consequent inquiries, especially for its role in children with asthma; necessitate scientific evaluation of influenza vaccination in the context of this country. Expand
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.
This ALVAC-HIV and AIDSVAX B/E vaccine regimen may reduce the risk of HIV infection in a community-based population with largely heterosexual risk and offer insight for future research. Expand
Intradermal Cell Culture Rabies Vaccine: A Cost Effective Option in Antirabies Treatment
This study highlights the economic advantages of using ID regimen, as theoretically only 0.8 ml of vaccine is needed for each patient resulting in use of less than 1 vial/patient as opposed to 5 vials/patient that receive PEP using IM route. Expand
Influenza a common viral infection among Hajj pilgrims: time for routine surveillance and vaccination.
A high incidence of influenza as a cause of upper respiratory tract infection among pilgrims is suggested, estimated to be 24,000 cases per Hajj season, excluding those becoming ill from contact with Hajj pilgrims returning home; and this indicates a very low vaccination rate for the influenza vaccine. Expand
Vaccine policy, regulations and safety in India
India is a major supplier of vaccines to UNICEF that in turn meets approximately 40% of the global vaccine demand for routine childhood vaccination in nearly 100 developing countries. Expand
[Immunization schedule].
The purpose of the recommended immunization schedule is to protect infants and children by providing immunity early in life, before they are exposed to potentially life-threatening diseases, according to the Centers for Disease Control and Prevention. Expand